argenx SE (ARGX)
892.16
-5.69
(-0.63%)
USD |
NASDAQ |
Oct 30, 16:00
898.99
+6.83
(+0.77%)
After-Hours: 18:10
argenx Cash and Short Term Investments (Annual) : 4.440B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 4.440B |
| December 31, 2024 | 3.379B |
| December 31, 2023 | 3.180B |
| December 31, 2022 | 2.193B |
| December 31, 2021 | 2.337B |
| December 31, 2020 | 1.996B |
| December 31, 2019 | 1.499B |
| December 31, 2018 | 647.32M |
| Date | Value |
|---|---|
| December 31, 2017 | 434.05M |
| December 31, 2016 | 102.85M |
| December 31, 2015 | 45.98M |
| December 31, 2014 | 67.73M |
| December 31, 2013 | 32.00M |
| December 31, 2012 | 21.73M |
| December 31, 2011 | 30.56M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Autolus Therapeutics Plc | 302.21M |
| Cellectis SA | 208.66M |
| Akari Therapeutics Plc | 5.263M |
| Forte Biosciences, Inc. | 76.96M |
| DBV Technologies SA | 194.17M |